U.S. Virus Guidelines Reject Trump-Backed Drug Combination (1)

April 21, 2020, 6:47 PM UTC

A panel of medical experts convened by the U.S. National Institutes of Health recommended against the use of a drug combination touted by President Donald Trump for Covid-19 patients.

The NIH panel, made up of 50 doctors, pharmacy experts and government researchers and officials, specifically recommended against the use of the anti-malaria drug hydroxychloroquine in combination with the antibiotic azithromycin.

The malaria pill can cause heart issues, and the NIH panel warned of the potential for harm from the combination.

Trump has repeatedly backed the use of the malaria pill or the combination of drugs on Twitter and at numerous ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.